TransScan's modified breast scanner gets FDA approval:
This article was originally published in Clinica
The US FDA has granted a supplementary premarket approval for a modified version of TransScan's TS-2000 breast scanning system. The instrument, which works by measuring the electrical impedance of tissue, received a PMA in April as an additional check following certain types of indecisive mammogram (ACR Bi-Rad categories 3 and 4) (see Clinica No 855, p 19). TransScan, of Ramsey, New Jersey, said the modifications were "advancements in the design and operation" of the system, which it distributes through Siemens Medical Systems.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.